Rachel D Pakenham, MSW | |
79 A La Grange, Fleming Circle, Frederiksted, VI 00841-0661 | |
(340) 772-3327 | |
Not Available |
Full Name | Rachel D Pakenham |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 36 Years |
Location | 79 A La Grange, Frederiksted, Virgin Island |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255483095 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | C002517 (North Carolina) | Secondary |
1041C0700X | Social Worker - Clinical | 2-2050103-2008 (Virgin Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rachel D Pakenham, MSW Po Box 661, Frederiksted, VI 00841-0661 Ph: (340) 772-5209 | Rachel D Pakenham, MSW 79 A La Grange, Fleming Circle, Frederiksted, VI 00841-0661 Ph: (340) 772-3327 |
News Archive
The number of COVID-19 variants is growing rapidly, so much that the scale and scope of mutation may pose a threat to the continuing successful use of the current vaccines and therapies.
In a new study, published in Current Biology, researchers from the University of California, Irvine School of Medicine reveal how subanesthetic ketamine, which is used for pain management and as an antidepressant in humans, is effective in treating adult amblyopia, a brain disorder commonly known as "lazy eye."
Researchers from the Department of Critical Care Medicine, Sichuan Provincial People's Hospital, Chengdu in China, have explored the possibility of using hydrogen therapy on severely ill COVID-19 patients. The team published their study's findings, titled "Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients," in the latest issue of the journal Frontiers in Pharmacology.
Diffusion Pharmaceuticals LLC announced today that it has opened for enrollment a clinical trial testing the company's lead drug candidate trans sodium crocetinate (TSC) as a first-line treatment for newly diagnosed primary brain cancer, also known as glioblastoma or GBM.
› Verified 2 days ago
Sherishma Chantell Pennyfeather, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1ab Estate Whim, Frederiksted, VI 00840 Phone: 340-226-5676 | |
Megan Burton, MSW, CISW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: #2a Estate Mt. Washington, Frederiksted, VI 00840 Phone: 340-473-0782 |